New thiazole and 1,2,4-triazole derivatives of 9,10-anthraquinone were obtained by the reaction of N-benzoyl-N'-(9,10-dioxo-9,10-dihydroanthracene-1-yl)-thioureas with bromoacetone in the presence of triethylamine and hydrazine hydrate in chloroform, respectively. The PASS computer program was used to predict the biological activity spectra and to determine the most promising biological activities for experimental testing. Thus, it has been shown that the synthesized compounds are a promising class for the creation of substances with a wide range of biological activity.
Introduction
The possibility of obtaining a large number of in practical terms valuable substances based on 9,10-anthraquinone derivatives is in accordance with the most important area of synthetic organic chemistry -the targeted synthesis of new organic compounds possessing a specified set of chemical, physical, and biological properties. An increasing number of publications about the synthesis and application of 9,10-anthraquinone derivatives testifies a continued interest in this series of compounds worldwide. Despite the widely studied chemistry of 9,10-anthraquinone, many classes of 9,10-anthraquinone derivatives remain scarcely explored.
On the other hand, N-aroylthioureas have a strong synthetic potential. They are important reagents for the synthesis of several heterocycles, such as imidazolidinyl-2-thiones [1, 2] , 2-aroyliminothiazolines [3] [4] [5] , 1,2,4-triazoles [6] , 1,3-thiazines [7] and indeno [1,2-d] [1, 3] thiazepines [8] . 2-Iminothiazolines are characterized by a wide range of biological properties [9] [10] [11] [12] . The thiazolidene-2-imine [13] or thiazol-2-imine [14] or 2-iminothiazoline [15] [16] [17] [18] ring system, as it has been named by different groups, is present in several drug candidates possessing interesting biological activities such as muscarinomimetic, antimycotic, hypolipemic, antidiabetic, thrombopoietinagonism, cell adhesion antagonists, platelet GPIIb/IIIa receptorantagonists, anti-inflammatory, analgesic and kinase (CDK1, CDK5 and GSK3) inhibition, schistosomicides, cadiotonicsand trichomonides [19] [20] [21] [22] [23] . Thiazoline derivatives have been found to exhibit promising applications in agriculture, such as acaricides, insecticides, and plant growth regulators [24, 25] . Recently, 2-iminothiazolines have been found to show antifungal activity [26] and skin whitening action [27] .
The 1H-1,2,4-triazole compounds show important pharmacological activities, e. g., antifungal and antiviral. Examples of such compounds bearing the 1,2,4-triazole residues are fluconazole [28] and ribavirin, the powerful azole antifungal agent as well as the potent antiviral N-nucleoside [29] . Furthermore, various 1,2,4-triazole derivatives have been reported as fungicidal [30] , insecticidal [31] , and antimicrobial [32] agents. Some of them have shown antitumor activity [33, 34] ; anticonvulsants [35] , antidepressants [36] , plant growth regulators, and anticoagulants [37] have been identified among them as well.
The reaction of N,N'-disubstituted thioureas with α-bromketones [5, 13] allows obtaining a variety of Nsubstituted 2-iminothiazoles. However, their derivatives that contain 9,10-dioxo-9,10-dihydroanthracenyl fragments at the 3 rd position of the heterocycle remain unknown up to date. 1,2,4-Triazole derivatives of 9,10-anthraquinone are also not described in the literature. Taking into account the known biological properties of anthraquinone derivatives [38] [39] [40] , it seems appropriate to design hybrid structures containing anthraquinone and thiazole or triazole cycles.
Materials and methods

1
H NMR and
13
C spectra were recorded with a Varian Mercury-400 spectrometer (400 and 100 MHz, respectively) at 25 °C in DMSO-d 6 , using TMS as an internal standard. IR spectra were obtained on a Specord M80 spectrophotometer, using KBr tablets. Chromatomass spectra were recorded on Agilent 110\DAD\HSD\VLG 119562 device. Melting points were determined with an automatic APA1 melting point apparatus and are uncorrected.
To a stirred suspension of 0.749 mmol of N-benzoylthiourea 1 a-e and of 0.104 ml (0.749 mmol) of triethylamine in 30 ml of acetone, at stirring, the solution of 0.0384 ml (0.749 mmol) of bromine in 10 ml of acetone was added over 10 min. The reaction mixture was kept at room temperature for 2 h, the precipitate formed was filtered, washed with acetone and water, dried, and recrystallized from toluene.
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amino]-anthracene-9,10-diones 3 а-е (general method). To a stirred suspension of 0.0518 mmol of N-benzoylthiourea 1 a-e in 30 ml of chloroform, 0.013 g (0.259 mmol) of hydrazine hydrate was added. The reaction mixture was heated under reflux for 5 h and cooled to room temperature. The precipitate formed was filtered, washed with water, and dried. 
Results and discussion
Computer prediction of biological activity spectra using the PASS software
The prediction of the biological activity spectra of the synthesized compounds was performed employing the PASS computer program (Prediction of Activity Spectra for Substances) [41, 42] . The latest PASS version (2012.11.22) predicts 6400 kinds of biological activity based on the analysis of the training set including information about ~330000 drugs, drug-candidates, lead compounds, etc. The average prediction accuracy estimated in a leave-one-out cross-validation procedure for the whole training set is about 95 %. The PASS online version is freely available for a scientific community on the website [43] . Based on the PASS predictions, new pharmaceutical agents from diverse chemical classes with various kinds of biological activity have been discovered [43] [44] [45] . The PASS output is presented by a list of probable activities with two estimated probabilities: Pathe probability to be "active", and Pi -the probability to be "inactive".
The higher the Pa value, the lower is the predicted probability of obtaining false positives in biological testing. For example, if one selects for testing only compounds for which a particular activity is predicted with Pa > 0.9, the expected probability to find inactive compounds in the selected set is very low; however, about 90 % of active compounds are missed. If one lowers the Pa threshold to 0.8, the probability to find inactive compounds is still low, but (only) about 80 % of active compounds are missed, etc. PASS uses the criteria Pa = Pi as the default threshold, i. e. all compounds with Pa >Pi are declared as being active.
The computer prediction using the PASS Online program for such well-known anticancer drugs based on aminoderivatives of 9,10-anthraquinone as Ametantron, Mitoxantrone, Banoxantron, and compounds on preclinical studies NSC-639365 and M-18 [46] was carried out. Results are in a complete agreement with the experimental data on anticancer activity ( The data obtained in experimental biological testing and calculated using the computer on-line PASS program provided the basis for predicting probable spectrum of anticancer activity of a series of new azole derivatives of 9,10-anthraquinone (Table 2) .
Some predicted typical pharmacological effects for ten new compounds -2-iminothiazoles 2 a-e and 1,2,4-triazoles 3 a-e -are shown in Table 2 (Pa > 0.4), which include: mucomembranous protector, transcription factor STAT3 inhibitor, antineoplastic, muramoyl-tetrapeptide carboxypeptidase inhibitor, angiogenesis inhibitor, 3-hydroxybenzoate 6-monooxygenase inhibitor, protein kinase inhibitor, pterin deaminase inhibitor, antiarthritic, etc. In the view of these data calculated using the PASS, the synthesis of new biheterocyclic structures, including 9,10-anthraquinone, and thiazole or triazole fragments seems reasonable.
Chemistry
Benzoylthioureas 1 a-e synthesized as described previously [47] were used to obtain new potentially antineoplastic derivatives of 9,10-anthraquinone. Their reaction with prepared in situ α-bromoacetone in acetone in the presence of triethylamine gave N-
)-9,10-dioxo-9,10-dihydroanthracen-1-yl)-4-methylthiazol-2(3H)-ylidene]benzamides 2 a-e in 48-68 % yields (Scheme 1).
According to literature data [5, 13] , a probable formation of the 2-iminothiazole cycle of compounds 2 a-e is presented in Scheme 2 and involves the initial attack of triethylamine on a more acidic imide proton of thiourea fragment 1 and the subsequent attack of a sulfur atom of thiourea on a carbon atom of the bromomethyl group of bromoacetone providing the isothiourea intermediate A. 
1a-e 2a-e The synthesis of novel 1,2,4-triazole derivatives of 9,10-anthraquinone was carried out by the procedure described in [6] . Benzoylthioureas 1 а-е were heated with hydrazine hydrate in a ratio of 1 : 5 in refluxing chloroform. As a result, triazolylaminoanthracenes 3 a-e were obtained with 60-81 % yields (Scheme 3). In the IR spectra of the synthesized compounds, characteristic absorption bands of two carbonyl groups of an anthraquinone fragment within the 1620-1685 cm 
Conclusions
New potentially biologically active N-(9,10-dioxo-9,10-dihydroanthracene-1-yl)-2-(N-benzoyilimino)thiazoles and [(5-phenyl-4H-1,2,4-triazol-3-yl)amino]anthracene-9,10-diones were obtained by the reaction of N-benzoyl-N'-(9,10-dioxo-9,10-dihydroanthracene-1-yl)thioureas with bromoacetone and hydrazine hydrate, respectively. The mechanism of N-[3-(R 1 ,R 2 ,R 3 )-9,10-dioxo-9,10-dihydroanthracen-1-yl)-4-methylthiazol-2(3H)-ylidene]benzamides formation was proposed. The biological activity spectra of the synthesized compounds have been estimated by using the PASS computer program.
